X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (64) 64
index medicus (40) 40
female (35) 35
middle aged (35) 35
male (32) 32
respiratory system (30) 30
adult (25) 25
aged (24) 24
treatment outcome (15) 15
analysis (13) 13
administration, inhalation (10) 10
beclomethasone - administration & dosage (10) 10
obstructive pulmonary-disease (10) 10
research (10) 10
animals (9) 9
double-blind (9) 9
double-blind method (9) 9
formoterol (9) 9
management (9) 9
obstetrics & gynecology (9) 9
corticosteroids (8) 8
exacerbations (8) 8
asthma (7) 7
clinical trials (7) 7
drug combinations (7) 7
formoterol fumarate - administration & dosage (7) 7
italy (7) 7
medicine & public health (7) 7
aged, 80 and over (6) 6
asthma - drug therapy (6) 6
chronic obstructive pulmonary disease (6) 6
disease progression (6) 6
diseases of the respiratory system (6) 6
lung - diagnostic imaging (6) 6
lungs (6) 6
physiological aspects (6) 6
pulmonary embolism - diagnosis (6) 6
retrospective studies (6) 6
safety (6) 6
therapy (6) 6
time factors (6) 6
tiotropium (6) 6
beclomethasone - adverse effects (5) 5
beclomethasone - therapeutic use (5) 5
beclomethasone dipropionate (5) 5
business (5) 5
care and treatment (5) 5
copd (5) 5
critical care medicine (5) 5
diagnosis (5) 5
dosage and administration (5) 5
drug therapy (5) 5
drug therapy, combination (5) 5
efficacy (5) 5
formoterol fumarate (5) 5
gynecology (5) 5
inhaled corticosteroids (5) 5
lung neoplasms - metabolism (5) 5
obstetrics and gynecology (5) 5
parallel-group (5) 5
pelvic organ prolapse (5) 5
prospective studies (5) 5
pulmonary disease, chronic obstructive - drug therapy (5) 5
pulmonary embolism (5) 5
pulmonary embolism - diagnostic imaging (5) 5
radiography (5) 5
radionuclide imaging (5) 5
risk assessment (5) 5
risk factors (5) 5
smoking - adverse effects (5) 5
surgery (5) 5
vaginal vault prolapse (5) 5
young adult (5) 5
abridged index medicus (4) 4
adolescent (4) 4
anti-asthmatic agents - administration & dosage (4) 4
budesonide/formoterol (4) 4
case studies (4) 4
chromatography, high pressure liquid (4) 4
forced expiratory volume (4) 4
further section (4) 4
glycopyrrolate - administration & dosage (4) 4
identification (4) 4
international journal of chronic obstructive pulmonary disease (4) 4
laparoscopic sacrocolpopexy (4) 4
lung (4) 4
lung - enzymology (4) 4
lung - metabolism (4) 4
lung diseases, obstructive (4) 4
oncology (4) 4
original paper (4) 4
patients (4) 4
prognosis (4) 4
pulmonary and respiratory medicine (4) 4
pulmonary disease, chronic obstructive - diagnosis (4) 4
pulmonary/respiratory (4) 4
review (4) 4
salmeterol (4) 4
severity of illness index (4) 4
smoking - metabolism (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10153, pp. 1113 - 1114
On the basis of previous studies,1,2 Marchand questions whether the withdrawal of inhaled corticosteroids (ICS) in a proportion of patients randomised to a... 
Administration, Inhalation | Bronchodilator Agents | Drug Therapy, Combination | Adrenal Cortex Hormones | Humans | Pulmonary Disease, Chronic Obstructive | Fees & charges | Pneumonia | Chronic obstructive pulmonary disease | Patients | Lung diseases | Obstructive lung disease
Journal Article
Technological Forecasting & Social Change, ISSN 0040-1625, 05/2019, Volume 142, pp. 312 - 321
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2005, Volume 353, Issue 21, pp. 2229 - 2242
Journal Article
Journal Article
Journal of Business Research, ISSN 0148-2963, 05/2019, Volume 98, pp. 204 - 213
The strategy literature has widely acknowledged the negative impact of cultural diversity between the partners of an alliance on their innovation performance.... 
Exploration | MNC subsidiary | Innovation performance | Cultural diversity | Strategic alliance | Exploitation | BIOTECHNOLOGY | DISTANCE | DETERMINANTS | RESEARCH-AND-DEVELOPMENT | KNOWLEDGE | BUSINESS | NATIONAL CULTURE | JOINT VENTURES | INTERNATIONALIZATION | ABSORPTIVE-CAPACITY | FIRM | Multiculturalism | International business enterprises | Business schools
Journal Article
Journal Article
International Journal of COPD, ISSN 1176-9106, 11/2017, Volume 12, pp. 3263 - 3271
The GOLD 2017 strategy document recommends that the pharmacological management of COPD patients be based on the risk of future exacerbations and the severity... 
Corticosteroid | GOLD 2017 | Exacerbations | GOLD B | COPD | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | exacerbations | corticosteroid | Complications and side effects | Lung diseases, Obstructive | Beclomethasone dipropionate | Formoterol | Dosage and administration | Research | Drug therapy
Journal Article
International Journal of COPD, ISSN 1176-9106, 2019, Volume 14, pp. 531 - 546
Background: Current pharmacological therapies for COPD improve quality of life and symptoms and reduce exacerbations. Given the progressive nature of COPD, it... 
Anticholinergics | Chronic obstructive pulmonary disease | Inhaled corticosteroids | Disease activity | Beta-2 agonists | PREVENTION | EXACERBATION FREQUENCY | HOSPITALIZATION | OBSTRUCTIVE PULMONARY-DISEASE | RESPIRATORY SYSTEM | PARALLEL-GROUP | disease activity | DOUBLE-BLIND | LUNG-FUNCTION DECLINE | POOLED ANALYSIS | INDACATEROL/GLYCOPYRRONIUM | anticholinergics | beta-2 agonists | POST-HOC ANALYSIS | chronic obstructive pulmonary disease | inhaled corticosteroids | Pulmonary Disease, Chronic Obstructive - mortality | Bronchodilator Agents - administration & dosage | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Forced Expiratory Volume | Time Factors | Adrenergic beta-2 Receptor Agonists - adverse effects | Female | Surveys and Questionnaires | Bronchodilator Agents - adverse effects | Glycopyrrolate - adverse effects | Pulmonary Disease, Chronic Obstructive - diagnosis | Beclomethasone - administration & dosage | Formoterol Fumarate - adverse effects | Administration, Inhalation | Treatment Outcome | Lung - physiopathology | Disease Progression | Randomized Controlled Trials as Topic | Adrenal Cortex Hormones - adverse effects | Muscarinic Antagonists - administration & dosage | Glycopyrrolate - administration & dosage | Lung - drug effects | Beclomethasone - adverse effects | Adrenergic beta-2 Receptor Agonists - administration & dosage | Aged | Drug Combinations | Nebulizers and Vaporizers | Adrenal Cortex Hormones - administration & dosage | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | obstructive pulmonary-disease | hospitalization | inhaled | post-hoc analysis | exacerbation frequency | pooled analysis | parallel-group | lung-function decline | Lungmedicin och allergi | Respiratory Medicine and Allergy | double-blind | prevention | indacaterol/glycopyrronium
Journal Article
Journal Article
Respiratory Research, ISSN 1465-993X, 2009, Volume 10, Issue 1, pp. 101 - 101
Journal Article
Respiratory Medicine, ISSN 0954-6111, 2016, Volume 114, pp. 84 - 90
Abstract This multicentre, double-blind, randomised, placebo-controlled, crossover study aimed to determine the dose-response of the long-acting muscarinic... 
Pulmonary/Respiratory | Bronchodilators | Extrafine | Triple therapy | COPD | Bronchodilator Agents - therapeutic use | Predictive Value of Tests | Glucocorticoids - administration & dosage | Forced Expiratory Volume - drug effects | Humans | Middle Aged | Male | Pulmonary Disease, Chronic Obstructive - physiopathology | Adrenergic beta-2 Receptor Agonists - pharmacology | Dose-Response Relationship, Drug | Vital Capacity - drug effects | Muscarinic Antagonists - pharmacology | Metered Dose Inhalers | Female | Pulmonary Disease, Chronic Obstructive - diagnosis | Beclomethasone - administration & dosage | Double-Blind Method | Formoterol Fumarate - pharmacology | Administration, Inhalation | Treatment Outcome | Cross-Over Studies | Beclomethasone - pharmacology | Muscarinic Antagonists - administration & dosage | Glycopyrrolate - administration & dosage | Glucocorticoids - pharmacology | Adrenergic beta-2 Receptor Agonists - administration & dosage | Glycopyrrolate - pharmacology | Aged | Drug Combinations | Formoterol Fumarate - administration & dosage | Pulmonary Disease, Chronic Obstructive - drug therapy | Beclomethasone dipropionate | Formoterol | Lung diseases, Obstructive | Corticosteroids | Analysis | Steroids | Respiratory therapy | Conflicts of interest | Chronic obstructive pulmonary disease | Clinical medicine | Pharmaceutical industry | Patients
Journal Article
International journal of chronic obstructive pulmonary disease, ISSN 1176-9106, 2018, Volume 13, pp. 3669 - 3676
Background: Growing evidence suggests that blood eosinophil count is associated with patient responsiveness to inhaled corticosteroids (ICS). We performed post... 
ICS | FEV1 | Lung function | COPD | VILANTEROL | RANDOMIZED CONTROLLED-TRIALS | OBSTRUCTIVE PULMONARY-DISEASE | lung function | RESPIRATORY SYSTEM | DOUBLE-BLIND | EXTRAFINE BECLOMETHASONE/FORMOTEROL | FLUTICASONE FUROATE | Medicine, Experimental | Medical research | Tiotropium | Lung diseases, Obstructive | Corticosteroids | chronic obstructive pulmonary disease
Journal Article